These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Metabolomic-proteomic combination analysis reveals the targets and molecular pathways associated with hydrogen sulfide alleviating NAFLD. Liu Z; Liu M; Fan M; Pan S; Li S; Chen M; Wang H Life Sci; 2021 Jan; 264():118629. PubMed ID: 33131747 [TBL] [Abstract][Full Text] [Related]
54. Zinc alpha2 glycoprotein protects against obesity-induced hepatic steatosis. Xiao XH; Wang YD; Qi XY; Wang YY; Li JY; Li H; Zhang PY; Liao HL; Li MH; Liao ZZ; Yang J; Xu CX; Wen GB; Liu JH Int J Obes (Lond); 2018 Aug; 42(8):1418-1430. PubMed ID: 30006580 [TBL] [Abstract][Full Text] [Related]
55. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis. Alonso C; Fernández-Ramos D; Varela-Rey M; Martínez-Arranz I; Navasa N; Van Liempd SM; Lavín Trueba JL; Mayo R; Ilisso CP; de Juan VG; Iruarrizaga-Lejarreta M; delaCruz-Villar L; Mincholé I; Robinson A; Crespo J; Martín-Duce A; Romero-Gómez M; Sann H; Platon J; Van Eyk J; Aspichueta P; Noureddin M; Falcón-Pérez JM; Anguita J; Aransay AM; Martínez-Chantar ML; Lu SC; Mato JM Gastroenterology; 2017 May; 152(6):1449-1461.e7. PubMed ID: 28132890 [TBL] [Abstract][Full Text] [Related]
56. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice. Gan L; Meng ZJ; Xiong RB; Guo JQ; Lu XC; Zheng ZW; Deng YP; Luo BD; Zou F; Li H Acta Pharmacol Sin; 2015 May; 36(5):597-605. PubMed ID: 25891086 [TBL] [Abstract][Full Text] [Related]
57. Omega-3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease. Shama S; Liu W Dig Dis Sci; 2020 Mar; 65(3):906-910. PubMed ID: 32036510 [TBL] [Abstract][Full Text] [Related]
58. Non-Alcoholic Fatty Liver Disease. Engin A Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211 [TBL] [Abstract][Full Text] [Related]
59. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease. Liu X; Chen S; Zhang L Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319 [TBL] [Abstract][Full Text] [Related]
60. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. Abenavoli L; Milic N; Di Renzo L; Preveden T; Medić-Stojanoska M; De Lorenzo A World J Gastroenterol; 2016 Aug; 22(31):7006-16. PubMed ID: 27610012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]